Hepatocellular carcinoma: Agents and concepts for preventing recurrence after curative treatment
โ Scribed by Hans J. Schlitt; Andreas A. Schnitzbauer
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 71 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22411
No coin nor oath required. For personal study only.
โฆ Synopsis
- Adjuvant/neoadjuvant chemotherapy. 2. Neoadjuvant transarterial chemoembolization. 3. Kinase inhibitors (eg, sorafenib). 4. Antiviral treatment. 5.Immunosuppressive treatment after liver transplantation. 6. Disseminated tumor cells: the basis for innovative treatment options?
๐ SIMILAR VOLUMES
Using selective angiograms of the liver, we analyzed the patterns of intrahepatic recurrence of hepatocellular carcinomas following curative surgery. In 33 patients with intraheptaic recurrences, seven patients (2 1 %) had a recurrence near the resected hepatic stump. The remaining 26 had either a n
Three tumor markers for hepatocellular carcinoma (HCC) are available in daily practice in Japan: alpha-fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP), and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3). To elucidate the predictability of these tumor markers on HCC
## BACKGROUND. Although several prognostic factors for patients w i t h gastric carcinoma have been demonstrated, those predictive of early and late recurrences after surgery are still unclear. METHODS. Of 479 patients who underwent curative resection for gastric carcinoma from 1977 to 1987, 115 p